                         SEQUENCE LISTING



<110>  Yeda Research and Development Co. Ltd.

       Seger, Rony

       Plotnikov, Alexander

 

<120>  ERK-DERIVED PEPTIDES AND USES THEREOF



<130>  60167



<150>  US 61/878,633

<151>  2013-09-17



<160>  10    



<170>  PatentIn version 3.5



<210>  1

<211>  16

<212>  PRT

<213>  Artificial sequence



<220>

<223>  Synthetic peptide (Scr)



<400>  1



Asn Ile Leu Ser Gln Glu Leu Pro His Ser Gly Asp Leu Gln Ile Gly 

1               5                   10                  15      





<210>  2

<211>  17

<212>  PRT

<213>  Artificial sequence



<220>

<223>  Synthetic peptide (SPS)



<400>  2



Gly Gln Leu Asn His Ile Leu Gly Ile Leu Gly Ser Pro Ser Gln Glu 

1               5                   10                  15      





Asp 

    





<210>  3

<211>  17

<212>  PRT

<213>  Artificial sequence



<220>

<223>  Synthetic peptide (APA)



<400>  3



Gly Gln Leu Asn His Ile Leu Gly Ile Leu Gly Ala Pro Ala Gln Glu 

1               5                   10                  15      





Asp 

    





<210>  4

<211>  17

<212>  PRT

<213>  Artificial sequence



<220>

<223>  A peptide capable of preventing extracellular signal-regulated 

       kinase1/2 (ERK) translocation into the nucleus





<220>

<221>  misc_feature

<222>  (12)..(12)

<223>  Xaa can be any naturally occurring amino acid



<220>

<221>  misc_feature

<222>  (14)..(14)

<223>  Xaa can be any naturally occurring amino acid



<400>  4



Gly Gln Leu Asn His Ile Leu Gly Ile Leu Gly Xaa Pro Xaa Gln Glu 

1               5                   10                  15      





Asp 

    





<210>  5

<211>  11

<212>  PRT

<213>  Artificial sequence



<220>

<223>  An example of a cell penetrating peptide (CPP) sequence



<400>  5



Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 

1               5                   10      





<210>  6

<211>  17

<212>  PRT

<213>  Artificial sequence



<220>

<223>  Synthetic peptide (EPE)



<400>  6



Gly Gln Leu Asn His Ile Leu Gly Ile Leu Gly Glu Pro Glu Gln Glu 

1               5                   10                  15      





Asp 

    





<210>  7

<211>  17

<212>  PRT

<213>  Artificial sequence



<220>

<223>  Synthetic peptide (DPD)



<400>  7



Gly Gln Leu Asn His Ile Leu Gly Ile Leu Gly Asp Pro Asp Gln Glu 

1               5                   10                  15      





Asp 

    





<210>  8

<211>  7

<212>  PRT

<213>  Artificial sequence



<220>

<223>  An example of a cell penetrating peptide (CPP) sequence



<400>  8



Tyr Gly Arg Lys Lys Arg Arg 

1               5           





<210>  9

<211>  11

<212>  PRT

<213>  Artificial sequence



<220>

<223>  An example of a cell penetrating peptide (CPP) sequence



<400>  9



Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 

1               5                   10      





<210>  10

<211>  5

<212>  PRT

<213>  Artificial sequence



<220>

<223>  An example of a cell penetrating peptide (CPP) sequence



<400>  10



Arg Arg Gln Arg Arg 

1               5   





